home / stock / data / data news

DATA News and Press, Tableau Software Inc. Class A From 07/27/21

Stock Information
Company Name: Tableau Software Inc. Class A
Stock Symbol: DATA
Market: NYSE
Menu
DATA DATA Quote DATA Short DATA News DATA Articles DATA Message Board
Get DATA Alerts

News, Short Squeeze, Breakout and More Instantly...
DATA - "The Buzz" Show: Relmada Therapeutics (NASDAQ: RLMD) Positive Drug Trial Results

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Relmada Therapeutics Stock Rises on Positive Drug Trial Results” Relmada Therapeutics (NASDAQ: RLMD) , Inc.climbed over 21% in premarket trading after the company ...
DATA - "The Buzz" Show: Lantern Pharma (NASDAQ: LTRN) Positive Cancer Collaboration Data

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Lantern Pharma Surged 10% Following Positive Cancer Collaboration Data ” Lantern Pharma (NASDAQ: LTRN) climbed over 10% in early morning trading after ...

DATA - "The Buzz" Show: Celldex Therapeutics, Inc. (NASDAQ: CLDX) Positive Trial Data

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Celldex Therapeutics, Inc. Shares Surge After Positive Trial Data ” Celldex Therapeutics, Inc. (NASDAQ: CLDX) climbed over 31% in premarket trading aft...

DATA - Tableau Foundation Teams up with Fair Count, Southern Economic Advancement Project to Make Data a Cornerstone of an Equitable Post-Pandemic Recovery

Tableau Foundation Teams up with Fair Count, Southern Economic Advancement Project to Make Data a Cornerstone of an Equitable Post-Pandemic Recovery Investments in data literacy across 12 states commits to the democratization of data to advance civic and economic engagement for ...
DATA - "The Buzz" Show: Ocuphire Pharma (NASDAQ: OCUP) Phase 2 Study Endpoint in Presbyopic Patients

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Ocuphire Pharma, Inc (NASDAQ: OCUP) Surges After VEGA-1 Phase 2 Trial Met Study Endpoints In Presbyopic Patients ” Ocuphire Pharma, Inc. (NASDAQ: OCUP) ...

DATA - "The Buzz" Show: Exela Technologies, Inc. (NASDAQ: XELA) Rollout of EON, Robotic Processing

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Exela Technologies, Inc. Surges Amid Providing EON Automation Platform to Health Insurance Company ” Exela Technologies, Inc. (NASDAQ: XELA) surged...

DATA - "The Buzz" Show: Cerevel Therapeutics (NASDAQ: CERE) Results for CVL-231 in Phase 1b Clinical Trial

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Cerevel Therapeutics Sees Positive Results for CVL-231 in Phase 1b Clinical Trial ” Cerevel Therapeutics (NASDAQ: CERE) surged over 59% in premarke...
DATA - "The Buzz" Show: Intellia Therapeutics, Inc. (NASDAQ: NTLA) Positive Gene Editing Data

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Intellia Therapeutics, Inc. Surges Following Positive Gene Editing Data ” Intellia Therapeutics, Inc. (NASDAQ: NTLA) surged over 59% in premarket tradi...

DATA - "The Buzz" Show: Geron Corporation (NASDAQ: GERN) IMbark Phase 2 Data: Journal of Clinical Oncology

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Geron Corporation Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology” Geron Corporation (NASDAQ: GERN) surged over 16% in premarket trading aft...

DATA - FDA Advisory Votes on Benefits of the Teplizumab to Outweigh Risks in Support of Approval to Delay Clinical Type 1 Diabetes

Provention Bio, Inc. (NASDAQ: PRVB) reported that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration voted 10 yes and 7 no on the question, “Does the information provided in the background documents and presentations by th...
Previous 10 Next 10